Hyderabad, Apr 26: Natco Pharma Limited on Monday said it applied to the Central Drugs Standard Control Organisation (CDSCO) for approval of Phase-III clinical trial of Molnupiravir Capsules for the treatment of COVID-19 positive patients.American pharma major Merck along withRidgeback Biotherapeuticshasdeveloped Molnupiravir(MK-4482).
from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/2QpH5mG
from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/2QpH5mG
This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.
Related Post
Joshimath: NDRF on standby to assist local administration, says officialThe team of the National Disaster Response Force (NDRF) rescuers have reached the location from the- With increasing Chinese outreach, India needs to enhance developmental diplomacy: MEA"In view of the increasing Chinese outreach and presence in India's neighbourhood, the Committee fe
- 2020 Delhi riots: Court frames charges against Tahir HussainNew Delhi, Jan 11: A court here on Wednesday paved the way for the commencement of trial by framing
- Health Minister Mandaviya reviews screening, Covid testing facility at Delhi airportAmid a spike in coronavirus cases in some countries, the government has sounded an alert, tightened
ConversionConversion EmoticonEmoticon